197 related articles for article (PubMed ID: 36287217)
21. Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study.
Tominaga A; Wada K; Kato Y; Nishi H; Terayama Y; Okazaki K
Osteoporos Int; 2021 Apr; 32(4):653-661. PubMed ID: 32979066
[TBL] [Abstract][Full Text] [Related]
22. Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study.
Ishibashi H; Crittenden DB; Miyauchi A; Libanati C; Maddox J; Fan M; Chen L; Grauer A
Bone; 2017 Oct; 103():209-215. PubMed ID: 28687496
[TBL] [Abstract][Full Text] [Related]
23. The impact of switching once-weekly teriparatide to denosumab in osteoporosis patients.
Miyagi M; Fujimaki H; Naruse K; Suto K; Inoue G; Nakazawa T; Imura T; Saito W; Uchida K; Shirasawa E; Takahira N; Takaso M
J Orthop Sci; 2019 Jan; 24(1):153-158. PubMed ID: 30146385
[TBL] [Abstract][Full Text] [Related]
24. Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment.
Tominaga A; Wada K; Okazaki K; Nishi H; Terayama Y; Kodama Y; Kato Y
Osteoporos Int; 2022 Jun; 33(6):1265-1273. PubMed ID: 35059774
[TBL] [Abstract][Full Text] [Related]
25. Romosozumab and antiresorptive treatment: the importance of treatment sequence.
Cosman F; Kendler DL; Langdahl BL; Leder BZ; Lewiecki EM; Miyauchi A; Rojeski M; McDermott M; Oates MK; Milmont CE; Libanati C; Ferrari S
Osteoporos Int; 2022 Jun; 33(6):1243-1256. PubMed ID: 35165774
[TBL] [Abstract][Full Text] [Related]
26. FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab.
Cosman F; Crittenden DB; Ferrari S; Khan A; Lane NE; Lippuner K; Matsumoto T; Milmont CE; Libanati C; Grauer A
J Bone Miner Res; 2018 Jul; 33(7):1219-1226. PubMed ID: 29573473
[TBL] [Abstract][Full Text] [Related]
27. T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial.
Cosman F; Lewiecki EM; Ebeling PR; Hesse E; Napoli N; Matsumoto T; Crittenden DB; Rojeski M; Yang W; Libanati C; Ferrari S
J Bone Miner Res; 2020 Jul; 35(7):1333-1342. PubMed ID: 32445228
[TBL] [Abstract][Full Text] [Related]
28. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
[TBL] [Abstract][Full Text] [Related]
29. Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: a 2-year observational study.
Hiramatsu R; Ubara Y; Sawa N; Sakai A
Nephrol Dial Transplant; 2021 Sep; 36(10):1900-1907. PubMed ID: 33544866
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the Efficacy of Zoledronate Acid or Denosumab After Switching from Romosozumab in Japanese Postmenopausal Patients.
Oue T; Shimizu T; Asano T; Shimodan S; Ishizu H; Arita K; Iwasaki N
Calcif Tissue Int; 2023 Jun; 112(6):683-690. PubMed ID: 37037949
[TBL] [Abstract][Full Text] [Related]
31. Predictors of denosumab efficacy in treating osteoporosis in patients with rheumatoid arthritis: a Japanese multicenter study.
Hattori K; Hirano Y; Kanayama Y; Takahashi N; Ishiguro N; Kojima T
Nagoya J Med Sci; 2019 Nov; 81(4):571-585. PubMed ID: 31849375
[TBL] [Abstract][Full Text] [Related]
32. Switching to Denosumab or Bisphosphonates After Completion of Teriparatide Treatment in Women With Severe Postmenopausal Osteoporosis.
Kocjan T; Rajic AS; Janez A; Vidmar G; Orehek N; Marc J; Ostanek B
Endocr Pract; 2021 Sep; 27(9):941-947. PubMed ID: 34111556
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for poor response to denosumab treatment in Japanese postmenopausal women with osteoporosis.
Okawa T; Okawa M; Koike T
J Bone Miner Metab; 2022 Nov; 40(6):960-967. PubMed ID: 35939236
[TBL] [Abstract][Full Text] [Related]
34. The effect of previous treatment with bisphosphonate and renal impairment on the response to denosumab in osteoporosis: a 'real-life' study.
Fraser TR; Flogaitis I; Moore AE; Hampson G
J Endocrinol Invest; 2020 Apr; 43(4):469-475. PubMed ID: 31664706
[TBL] [Abstract][Full Text] [Related]
35. Standard Versus Cyclic Teriparatide and Denosumab Treatment for Osteoporosis: A Randomized Trial.
Cosman F; McMahon D; Dempster D; Nieves JW
J Bone Miner Res; 2020 Feb; 35(2):219-225. PubMed ID: 31419313
[TBL] [Abstract][Full Text] [Related]
36. Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial.
Miyauchi A; Hamaya E; Yang W; Nishi K; Libanati C; Tolman C; Shimauchi J
J Bone Miner Metab; 2021 Mar; 39(2):278-288. PubMed ID: 33057807
[TBL] [Abstract][Full Text] [Related]
37. Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study.
Silverman SL; Siris E; Belazi D; Recknor C; Papaioannou A; Brown JP; Gold DT; Lewiecki EM; Quinn G; Balasubramanian A; Yue S; Stolshek B; Kendler DL
Arch Osteoporos; 2018 Aug; 13(1):85. PubMed ID: 30088189
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
Hara T; Hijikata Y; Matsubara Y; Watanabe N
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
[TBL] [Abstract][Full Text] [Related]
39. Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency.
Miyaoka D; Imanishi Y; Ohara M; Hayashi N; Nagata Y; Yamada S; Mori K; Emoto M; Inaba M
Osteoporos Int; 2019 Jan; 30(1):241-249. PubMed ID: 30187112
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study.
Sato M; Inaba M; Yamada S; Emoto M; Ohno Y; Tsujimoto Y
J Bone Miner Metab; 2021 Nov; 39(6):1082-1090. PubMed ID: 34324082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
